A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis

Conditions: Psoriasis Vulgaris; Psoriatic Arthritis Interventions: Drug: si-544; Drug: Placebo Sponsors: selectION Therapeutics GmbH; FGK Clinical Research GmbH Not yet recruiting

https://clinicaltrials.gov/study/NCT06191042

Source: ClinicalTrials.gov - January 4, 2024 Category: Research Source Type: clinical trials